NCAM1 and neoplasm: Fig 8A shows representative tumor sections stained with fluorescent anti-CD56 (red) and DAPI (blue) that received ldbFUS/0.50MPa on one tumor (upper panel) and sections from the contralateral control tumor (lower panel) from an NSG mouse. Quantitation of percent NK cells (mean±SD, CD56 positive counts per total tumor cell count) showed that (+)ldbFUS/0.50MPa (1.21±0.32%) had significantly higher counts than the (-)ldbFUS/0.50MPa control tumor (0.37±0.17%) (Fig 8C).